Cargando…
Early Mechanisms of Chemoresistance in Retinoblastoma
SIMPLE SUMMARY: Despite advances in chemotherapy for retinoblastoma over the past three decades, chemoresistance remains a major source of ocular and systemic morbidity. Here, we studied the early molecular mechanisms leading to carboplatin resistance. Carboplatin is one of the most widely used agen...
Autores principales: | Zhang, Michelle G., Kuznetsoff, Jeffim N., Owens, Dawn A., Gallo, Ryan A., Kalahasty, Karthik, Cruz, Anthony M., Kurtenbach, Stefan, Correa, Zelia M., Pelaez, Daniel, Harbour, J. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563111/ https://www.ncbi.nlm.nih.gov/pubmed/36230889 http://dx.doi.org/10.3390/cancers14194966 |
Ejemplares similares
-
RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022) -
PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023) -
BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas
por: Kaler, Christopher J., et al.
Publicado: (2022) -
Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging
por: Ashkenazy, Noy, et al.
Publicado: (2022) -
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
por: Kuznetsov, Jeffim N., et al.
Publicado: (2019)